← All Mutual Funds

abrdn Healthcare Opportunities Fund

CIK: 0001604522 THQ Equity
Report date: 2026-02-27
AUM $791M
Expense Ratio
Category Equity
State MA
Fiscal Year End
Inception Date
Manager
Latest Filing 2026-02-27

About this Fund

The abrdn Healthcare Opportunities Fund is a leading mutual fund company specializing in providing investors with a diverse range of investment opportunities across the healthcare sector. As a prominent player in the asset management industry, abrdn offers a comprehensive portfolio of mutual funds that cater to various investor preferences, including equity, debt, and hybrid funds. By focusing on the rapidly evolving healthcare landscape, the company enables investors to capitalize on the growth potential of this critical sector, which is driven by an aging population, advancements in medical technology, and an increasing demand for healthcare services. With a strong emphasis on wealth management, abrdn's investment approach is centered on delivering long-term value to its investors, who can benefit from the company's extensive expertise in navigating the complexities of the healthcare market. The abrdn Healthcare Opportunities Fund is designed to provide investors with a strategic investment vehicle that leverages the company's in-depth knowledge of the healthcare industry, allowing them to make informed investment decisions. By investing in a diversified portfolio of healthcare-related stocks, bonds, and other securities, investors can mitigate risk while tapping into the sector's growth potential. The company's investment strategy is built around a rigorous research process, which involves identifying high-quality investment opportunities and conducting thorough due diligence to ensure that investors' interests are protected. abrdn's commitment to transparency, accountability, and investor-centricity has earned the trust of its clients, who appreciate the company's dedication to providing tailored investment solutions that meet their unique needs and goals. Whether investors are seeking to grow their wealth over the long term or generate regular income through systematic investment plans (SIPs), the abrdn Healthcare Opportunities Fund offers a flexible and reliable investment platform that aligns with their objectives. With a proven track record of delivering strong investment performance, the abrdn Healthcare Opportunities Fund has established itself as a trusted partner for investors seeking to capitalize on the healthcare sector's growth potential. By combining its deep understanding of the healthcare industry with a disciplined investment approach, abrdn has built a reputation for excellence in asset management, which is reflected in its ability to attract and retain a loyal client base. As a specialist in mutual fund management, the company continues to innovate and expand its product offerings, ensuring that investors have access to a broad range of investment opportunities that cater to their evolving needs and risk profiles. By focusing on the healthcare sector, abrdn is well-positioned to capitalize on the sector's long-term growth potential, driven by demographic trends, technological advancements, and an increasing focus on healthcare as a critical component of economic development. As a result, investors can trust the abrdn Healthcare Opportunities Fund to provide them with a reliable and effective investment platform that supports their wealth management goals and aspirations.

Holdings

From latest SEC N-PORT filing · US-listed stocks only

51 positions
# Security Name CUSIP Asset Type Weight % Value ($M) Quantity
1 ABT Abbott Laboratories Since 2026-05-10 002824100 Equity (Common)
6.29%
$49.75 397,060
2 ABT ABBOTT LABORATORIES Since 2026-05-10 002824BG4 Debt
1.34%
$10.56 10,498,000
3 ABBV AbbVie Inc Since 2026-05-10 00287Y109 Equity (Common)
7.22%
$57.11 249,937
4 ABBV ABBVIE INC Since 2026-05-10 00287YAW9 Debt
0.34%
$2.68 3,080,000
5 ABBV ABBVIE INC Since 2026-05-10 00287YAY5 Debt
0.41%
$3.24 3,245,000
6 ABBV ABBVIE INC Since 2026-05-10 00287YBF5 Debt
0.68%
$5.36 5,303,000
7 AMGN Amgen Inc Since 2026-05-10 031162100 Equity (Common)
0.66%
$5.21 15,909
8 AMGN AMGEN INC Since 2026-05-10 031162CQ1 Debt
0.27%
$2.17 2,200,000
9 AMGN AMGEN INC Since 2026-05-10 031162CZ1 Debt
0.31%
$2.44 2,795,000
10 RCUS Arcus Biosciences Inc Since 2026-05-10 03969F109 Equity (Common)
0.38%
$3.01 126,168
11 AZN ASTRAZENECA PLC Since 2026-05-10 046353AD0 Debt
0.68%
$5.41 4,750,000
12 BCRX BioCryst Pharmaceuticals Inc Since 2026-05-10 09058V103 Equity (Common)
0.33%
$2.60 333,618
13 CDNA CareDx Inc Since 2026-05-10 14167L103 Equity (Common)
0.50%
$3.98 211,434
14 CRL Charles River Laboratories International Inc Since 2026-05-10 159864107 Equity (Common)
0.83%
$6.58 32,984
15 DXCM Dexcom Inc Since 2026-05-10 252131107 Equity (Common)
0.96%
$7.60 114,502
16 IRON Disc Medicine Inc Since 2026-05-10 254604101 Equity (Common)
0.67%
$5.31 66,869
17 DHC Diversified Healthcare Trust Since 2026-05-10 25525P107 Equity (Common)
0.18%
$1.43 293,879
18 GILD GILEAD SCIENCES INC Since 2026-05-10 375558BM4 Debt
1.25%
$9.90 10,000,000
19 DOC Healthpeak Properties Inc Since 2026-05-10 42250P103 Equity (Common)
1.26%
$9.98 620,394
20 HUM Humana Inc Since 2026-05-10 444859102 Equity (Common)
2.76%
$21.86 85,345
21 INSP Inspire Medical Systems Inc Since 2026-05-10 457730109 Equity (Common)
2.25%
$17.81 193,095
22 ISRG Intuitive Surgical Inc Since 2026-05-10 46120E602 Equity (Common)
4.03%
$31.86 56,256
23 IQV IQVIA Holdings Inc Since 2026-05-10 46266C105 Equity (Common)
0.56%
$4.45 19,723
24 LTC LTC Properties Inc Since 2026-05-10 502175102 Equity (Common)
0.73%
$5.74 166,842
25 LUCD Lucid Diagnostics Inc Since 2026-05-10 54948X109 Equity (Common)
0.48%
$3.77 3,457,894
26 MPT Medical Properties Trust Inc Since 2026-05-10 58463J304 Equity (Common)
0.17%
$1.33 266,557
27 MRK Merck & Co Inc Since 2026-05-10 58933Y105 Equity (Common)
6.11%
$48.33 459,113
28 MRK MERCK & CO INC Since 2026-05-10 58933YAX3 Debt
0.50%
$3.94 4,000,000
29 MOH Molina Healthcare Inc Since 2026-05-10 60855R100 Equity (Common)
1.56%
$12.33 71,056
30 MYGN Myriad Genetics Inc Since 2026-05-10 62855J104 Equity (Common)
0.69%
$5.45 885,801
31 NHI National Health Investors Inc Since 2026-05-10 63633D104 Equity (Common)
0.05%
$0.43 5,596
32 NEO NeoGenomics Inc Since 2026-05-10 64049M209 Equity (Common)
1.51%
$11.96 1,017,151
33 OHI Omega Healthcare Investors Inc Since 2026-05-10 681936100 Equity (Common)
1.67%
$13.21 297,889
34 PFE PFIZER INC Since 2026-05-10 717081EC3 Debt
0.38%
$3.00 3,200,000
35 PFE PFIZER INC Since 2026-05-10 717081ET6 Debt
1.01%
$8.01 8,100,000
36 PRAX Praxis Precision Medicines Inc Since 2026-05-10 74006W207 Equity (Common)
1.38%
$10.94 37,107
37 REGN Regeneron Pharmaceuticals Inc Since 2026-05-10 75886F107 Equity (Common)
1.49%
$11.78 15,260
38 SBRA Sabra Health Care REIT Inc Since 2026-05-10 78573L106 Equity (Common)
1.50%
$11.87 626,862
39 SRPT Sarepta Therapeutics Inc Since 2026-05-10 803607100 Equity (Common)
2.43%
$19.23 893,720
40 SERA Sera Prognostics Inc Since 2026-05-10 81749D107 Equity (Common)
0.42%
$3.35 1,133,977
41 SPRY ARS Pharmaceuticals Inc Since 2026-05-10 82835W108 Equity (Common)
2.09%
$16.52 1,417,732
42 TNDM Tandem Diabetes Care Inc Since 2026-05-10 875372203 Equity (Common)
0.72%
$5.69 258,774
43 TMO Thermo Fisher Scientific Inc Since 2026-05-10 883556102 Equity (Common)
3.61%
$28.52 49,225
44 TMO THERMO FISHER SCIENTIFIC Since 2026-05-10 883556CY6 Debt
0.83%
$6.54 6,500,000
45 VTR Ventas Inc Since 2026-05-10 92276F100 Equity (Common)
1.19%
$9.39 121,336
46 WELL Welltower Inc Since 2026-05-10 95040Q104 Equity (Common)
1.36%
$10.75 57,915
47 ZBH ZIMMER BIOMET HOLDINGS Since 2026-05-10 98956PAG7 Debt
0.71%
$5.58 6,000,000
48 ZTS Zoetis Inc Since 2026-05-10 98978V103 Equity (Common)
2.82%
$22.28 177,071
49 MDT Medtronic PLC Since 2026-05-10 Equity (Common)
4.27%
$33.74 351,290
50 PCSC Perceptive Capital Solutions Corp Since 2026-05-10 Equity (Common)
0.35%
$2.77 212,600
51 OCS Oculis Holding AG Since 2026-05-10 Equity (Common)
1.44%
$11.38 569,796
Frequently Asked Questions — abrdn Healthcare Opportunities Fund
What type of mutual fund is abrdn Healthcare Opportunities Fund?
abrdn Healthcare Opportunities Fund is a SEC-registered Equity fund, with $791M in assets under management. Equity funds invest primarily in a diversified portfolio of stocks and equities, aiming for long-term capital appreciation. They carry higher market risk than bond or money market funds but historically offer stronger long-term returns. Equity mutual funds can be further classified as large-cap, mid-cap, small-cap, growth, value, or sector-specific depending on their investment mandate. As of its latest SEC N-PORT filing, abrdn Healthcare Opportunities Fund holds 51 portfolio positions, all detailed in the holdings table on this page.
What are abrdn Healthcare Opportunities Fund's assets under management (AUM)?
abrdn Healthcare Opportunities Fund has $791M in assets under management (AUM) according to its most recent SEC N-PORT filing on StockSifting. AUM represents the total market value of all securities and other assets held by the fund as of the report date. A larger AUM generally signals a more established fund with greater institutional adoption, more trading liquidity, and potentially lower per-unit operational costs due to economies of scale. AUM changes daily as market prices fluctuate and as investors purchase or redeem fund shares — the figure shown here reflects the most recently available N-PORT disclosure, not the current real-time value. For the live figure, consult the fund's official website or its latest SEC EDGAR filing.
What are abrdn Healthcare Opportunities Fund's top holdings?
According to abrdn Healthcare Opportunities Fund's most recent SEC N-PORT filing, the fund's largest holdings by portfolio weight include Abbott Laboratories, ABBOTT LABORATORIES, AbbVie Inc , among others. The complete list of all 51 holdings — including CUSIP, asset type, portfolio weight percentage, dollar value, and share quantity — is available in the holdings table above. Holdings data is sourced directly from SEC EDGAR N-PORT filings and reflects the fund's positions as of the report date shown at the top of this page. Due to the 60-day SEC disclosure lag, these positions may differ from the fund's current portfolio. For the latest holdings before public release, refer to SEC EDGAR directly.
What is abrdn Healthcare Opportunities Fund's expense ratio?
Expense ratio data for abrdn Healthcare Opportunities Fund is not currently available in StockSifting's database. The expense ratio is the annual fee charged by a mutual fund as a percentage of your investment, covering management fees and operational costs. It is one of the most important factors affecting net long-term returns — lower expense ratios allow more of a fund's gross performance to flow through to investors. For the most accurate and current expense ratio, refer to the fund's official prospectus or its SEC EDGAR filings. You can also contact us if you believe this data should be present.
Where can I find abrdn Healthcare Opportunities Fund's SEC filings?
abrdn Healthcare Opportunities Fund is required to file monthly portfolio reports (Form N-PORT) with the U.S. Securities and Exchange Commission (SEC). Its SEC Central Index Key (CIK) is 0001604522. You can access all of abrdn Healthcare Opportunities Fund's SEC filings — including N-PORT holdings disclosures, annual reports (Form N-CEN), and registration statements — directly on SEC EDGAR (CIK: 0001604522). N-PORT filings disclose the fund's complete portfolio holdings, fair value measurements, and certain risk metrics as of each filing period end date. StockSifting automatically parses these filings to populate the holdings table, AUM figures, and expense ratio displayed on this page, making the raw EDGAR data accessible without needing to download and parse XML files manually.
How current is abrdn Healthcare Opportunities Fund's holdings data on StockSifting?
Holdings data for abrdn Healthcare Opportunities Fund on StockSifting is sourced from its most recent SEC EDGAR N-PORT filing. Under SEC rules, registered investment companies must file N-PORT reports monthly, but these are made publicly available approximately 60 days after the reporting period end date. This means the holdings shown on this page reflect the fund's portfolio from roughly two months prior — not today's exact positions. The Report date displayed at the top of this page indicates exactly when the underlying data was current. If the fund has made significant portfolio changes since that date — responding to market events, earnings releases, or macro shifts — those changes will not be reflected here until the next N-PORT filing is released. For the most up-to-date holdings before the public disclosure window, refer to the fund's official website or SEC EDGAR directly. StockSifting is best used for fundamental research and historical portfolio analysis, not real-time trading decisions.